Log in to save to my catalogue

Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic revi...

Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic revi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67899297

Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review

About this item

Full title

Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review

Publisher

Heidelberg: Springer

Journal title

Intensive care medicine, 2006-05, Vol.32 (5), p.650-657

Language

English

Formats

Publication information

Publisher

Heidelberg: Springer

More information

Scope and Contents

Contents

Chylothorax is a rare but life-threatening condition in children. To date, there is no commonly accepted treatment protocol. Somatostatin and octreotide have recently been used for treating chylothorax in children. We set out to summarise the evidence on the efficacy and safety of somatostatin and octreotide in treating young children with chylotho...

Alternative Titles

Full title

Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67899297

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67899297

Other Identifiers

ISSN

0342-4642

E-ISSN

1432-1238

DOI

10.1007/s00134-006-0114-9

How to access this item